Using SPR, PLA and Western blot assay as well as cell proliferation activity, we have shown that compound 18 binds to domain IV of HER2, inhibits dimerization, HER2 kinase phosphorylation, downstream signaling Akt and hence cell proliferation in lung cancer cell lines. The gene discussed is AKT1; the disease is lung carcinoma.